보툴리눔톡신(보톡스) 시장 규모 조사 : 용도별, 유형별, 최종사용자별, 지역별 예측(2022-2032년)

Global Botulinum Toxin Market is valued at approximately USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.9% over the forecast period 2024-2032. Botulinum toxin, a neurotoxin produced by the gram-positive anaerobic bacterium Clostridium botulinum, is available in Type A and Type B forms, and extensively used in therapeutic and aesthetic procedures. These toxins, known for their distinct antigenic and serological characteristics, have been pivotal in the growing demand for non-invasive cosmetic procedures. The surge in disposable incomes, favorable reimbursement policies, and continuous product innovations by market players have substantially driven the market.

The rising preference for non-invasive procedures significantly boosts the market. According to the International Society of Aesthetic Plastic Surgery (ISAPS) 2022 report, an estimated 18.86 million nonsurgical procedures were performed globally in 2021, with botulinum toxin procedures accounting for a substantial portion. The ongoing rise in R&D initiatives to expand aesthetic and therapeutic applications further propels market growth. For instance, in July 2022, AbbVie Inc. conducted a study on BOTOX injections to assess changes in patients suffering from upper limb essential tremors. Moreover, raising awareness through promotional activities, expanding in emerging markets, and embracing technological advancements and innovations offer various lucrative opportunities in the coming years. However, the market faces challenges due to the proliferation of counterfeit products, which pose significant health risks and affect the revenues of genuine product manufacturers. Regulatory bodies like the U.S. FDA and WHO have issued warnings and seized counterfeit shipments to mitigate these risks. However, the increasing presence of counterfeit products and concerns regarding regulations and safety are posing challenges to market growth throughout the forecast period of 2024-2032.

The key regions considered for the Global Botulinum Toxin Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Global Botulinum Toxin Market in terms of revenue. The market growth in the region is being attributed to factors including numerous product launches and increasing regulatory approvals. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by rising chronic diseases and growing awareness of physical appearance, supported by extensive research efforts.

Major market players included in this report are:

• AbbVie Inc.
• Ipsen Pharma
• Merz Pharma
• Medytox
• GALDERMA
• Lanzhou Institute of Biological Products Co., Ltd.
• HUGEL, Inc.
• Evolus, Inc.
• Revance Therapeutics, Inc.
• Supernus Pharmaceuticals, Inc.
• Daewoong Pharmaceutical Co., Ltd.
• Sihuan Pharmaceutical Holdings Group Ltd.
• Metabiologics, Inc.
• Hefei Huateng Pharmaceutical Co., Ltd.
• PharmaResearch Products Co., Ltd.

The detailed segments and sub-segment of the market are explained below:

By Application:

• Therapeutics
• Aesthetics

By Type:

• Botulinum Toxin Type A
• Botulinum Toxin Type B

By End-User:

• Specialty & Dermatology Clinics
• Hospitals & Clinics
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Botulinum Toxin Market Executive Summary

• 1.1. Global Botulinum Toxin Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Application
  • 1.3.2. By Type
  • 1.3.3. By End-User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Botulinum Toxin Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Botulinum Toxin Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Robust Demand for Non-Invasive Procedures
  • 3.1.2. Significant Rise in R&D Initiatives
  • 3.1.3. Increasing Disposable Income and Favorable Reimbursement Policies
• 3.2. Market Challenges
  • 3.2.1. Growing Presence and Access to Counterfeit Products
  • 3.2.2. Regulatory and Safety Concerns
• 3.3. Market Opportunities
  • 3.3.1. Dissemination of Awareness through Promotional Activities
  • 3.3.2. Expansion in Emerging Markets
  • 3.3.3. Technological Advancements and Innovations

Chapter 4. Global Botulinum Toxin Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunity
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Botulinum Toxin Market Size & Forecasts by Application 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Botulinum Toxin Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Therapeutics
  • 5.2.2. Aesthetics

Chapter 6. Global Botulinum Toxin Market Size & Forecasts by Type 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Botulinum Toxin Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Botulinum Toxin Type A
  • 6.2.2. Botulinum Toxin Type B

Chapter 7. Global Botulinum Toxin Market Size & Forecasts by End-User 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Botulinum Toxin Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Specialty & Dermatology Clinics
  • 7.2.2. Hospitals & Clinics
  • 7.2.3. Others

Chapter 8. Global Botulinum Toxin Market Size & Forecasts by Region 2022-2032

• 8.1. North America Botulinum Toxin Market
  • 8.1.1. U.S. Botulinum Toxin Market
    • 8.1.1.1. Application breakdown size & forecasts, 2022-2032
    • 8.1.1.2. Type breakdown size & forecasts, 2022-2032
    • 8.1.1.3. End-User breakdown size & forecasts, 2022-2032
  • 8.1.2. Canada Botulinum Toxin Market
• 8.2. Europe Botulinum Toxin Market
  • 8.2.1. U.K. Botulinum Toxin Market
  • 8.2.2. Germany Botulinum Toxin Market
  • 8.2.3. France Botulinum Toxin Market
  • 8.2.4. Spain Botulinum Toxin Market
  • 8.2.5. Italy Botulinum Toxin Market
  • 8.2.6. Rest of Europe Botulinum Toxin Market
• 8.3. Asia-Pacific Botulinum Toxin Market
  • 8.3.1. China Botulinum Toxin Market
  • 8.3.2. India Botulinum Toxin Market
  • 8.3.3. Japan Botulinum Toxin Market
  • 8.3.4. Australia Botulinum Toxin Market
  • 8.3.5. South Korea Botulinum Toxin Market
  • 8.3.6. Rest of Asia Pacific Botulinum Toxin Market
• 8.4. Latin America Botulinum Toxin Market
  • 8.4.1. Brazil Botulinum Toxin Market
  • 8.4.2. Mexico Botulinum Toxin Market
  • 8.4.3. Rest of Latin America Botulinum Toxin Market
• 8.5. Middle East & Africa Botulinum Toxin Market
  • 8.5.1. Saudi Arabia Botulinum Toxin Market
  • 8.5.2. South Africa Botulinum Toxin Market
  • 8.5.3. Rest of Middle East & Africa Botulinum Toxin Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. AbbVie Inc.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Market Strategies
  • 9.3.2. Ipsen Pharma
  • 9.3.3. Merz Pharma
  • 9.3.4. Medytox
  • 9.3.5. GALDERMA
  • 9.3.6. Lanzhou Institute of Biological Products Co., Ltd.
  • 9.3.7. HUGEL, Inc.
  • 9.3.8. Evolus, Inc.
  • 9.3.9. Revance Therapeutics, Inc.
  • 9.3.10. Supernus Pharmaceuticals, Inc.
  • 9.3.11. Daewoong Pharmaceutical Co., Ltd.
  • 9.3.12. Sihuan Pharmaceutical Holdings Group Ltd.
  • 9.3.13. Metabiologics, Inc.
  • 9.3.14. Hefei Huateng Pharmaceutical Co., Ltd.
  • 9.3.15. PharmaResearch Products Co., Ltd.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes